Ms. Hoffman began her career as a wound care nurse before joining Convatec, a division of Bristol Myers Squibb, in sales and clinical research.
She spent several years in business development for a CRO before joining Johnson & Johnson, where she was a Global Trial Manager and Clinical Program Lead in bipolar disorder, schizophrenia, autism and GI disorders, with a focus in pediatrics.
She was a pioneer in informed consent and assent workshops and recruitment, and part of an EU team to streamline informed consent and assent across countries.